| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |